欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IE/H/0196/004
药品名称Lamictal tablets 200mg
活性成分
    • lamotrigine 200.0 mg
剂型Tablet
上市许可持有人New RMS: NL/H/1540/01-04 Name and address of the MAH: GlaxoSmithKline B.V., Huis ter Heideweg 62 3705 LZ Zeist, The Netherlands Former RMS: IE/H/196/1-4 GlaxoSmithKline (Ireland) Limited Stonemasons Way Rathfarnham, Dublin 16, Ireland
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • Netherlands (NL)
      Lamictal 200 mg tabletten
许可日期2008/09/08
最近更新日期2009/04/23
药物ATC编码
    • N03AX09 lamotrigine
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Repeat Use
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase